These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26621797)

  • 21. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project.
    Stefano B; Pietro RR; Maurizio G; Maurizio L; Renato M; Maurizio L; Pietro R; Alessandro P; Gianluca B; Monica M; Sergio C; Massimo S
    Am Heart J; 2011 Aug; 162(2):390-7. PubMed ID: 21835302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
    Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
    Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of defibrillation testing.
    Amit G; Healey JS
    Card Electrophysiol Clin; 2015 Sep; 7(3):539-46. PubMed ID: 26304533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009.
    Bradshaw PJ; Stobie P; Briffa T; Hobbs MS
    Am Heart J; 2013 May; 165(5):816-22. PubMed ID: 23622920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis.
    Stavrakis S; Patel NH; Reynolds DW
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1402-8. PubMed ID: 23875736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does defibrillation testing influence outcomes after CRT-D implantation? A cause-of-death analysis from the DAI-PP study.
    Perrin T; Mechulan A; Boveda S; Beganton F; Defaye P; Sadoul N; Piot O; Klug D; Gras D; Perier MC; Algalarrondo V; Bordachar P; Babuty D; Fauchier L; Leclercq C; Marijon E; Deharo JC;
    Int J Cardiol; 2016 Oct; 221():951-6. PubMed ID: 27441474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defibrillation threshold testing: tradition or necessity?
    Kolb C; Tzeis S; Zrenner B
    Pacing Clin Electrophysiol; 2009 May; 32(5):570-2; discussion 572. PubMed ID: 19422576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [35 year ICD therapy: Where does it come from and where does it go?].
    Israel CW
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):59-60. PubMed ID: 26031514
    [No Abstract]   [Full Text] [Related]  

  • 31. [Not Available].
    Muggli B; Gruner C
    Ther Umsch; 2016; 73(12):759-765. PubMed ID: 28462616
    [No Abstract]   [Full Text] [Related]  

  • 32. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative considerations during implantation of the subcutaneous defibrillator: State-of-the-art review.
    Singh P; Afzal MR; Weiss R
    Pacing Clin Electrophysiol; 2020 Dec; 43(12):1451-1458. PubMed ID: 32926443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defibrillation Testing Strategies of Pediatric and Adult Congenital Electrophysiologists during ICD Implantation.
    Baysa SJ; Olen M; Kanter RJ; Fishberger SB
    Pacing Clin Electrophysiol; 2016 Aug; 39(8):843-7. PubMed ID: 27226114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of Shock from Defibrillation Threshold Testing on Cardiac Systolic and Diastolic Function.
    Kodani T; Mine T; Kishima H; Masuyama T
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):999-1005. PubMed ID: 27380898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac troponin levels following implantable cardioverter defibrillation implantation and testing.
    Furniss G; Shi B; Jimenez A; Harding SA; Larsen PD
    Europace; 2015 Feb; 17(2):262-6. PubMed ID: 25414480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial.
    Aoukar PS; Poole JE; Johnson GW; Anderson J; Hellkamp AS; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2013 Jul; 10(7):970-6. PubMed ID: 23562699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?
    Russo AM; Sauer W; Gerstenfeld EP; Hsia HH; Lin D; Cooper JM; Dixit S; Verdino RJ; Nayak HM; Callans DJ; Patel V; Marchlinski FE
    Heart Rhythm; 2005 May; 2(5):456-61. PubMed ID: 15840466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.